Company intelligence / Profile preview

Saneso

Ownership: Private
Employees: ~37
Development stage: Commercial

Overview

Saneso has developed a novel five-camera colonoscope that provides a full 360° view inside the gastrointestinal tract, addressing limitations in traditional colonoscopes which can miss up to 40% of polyps. The device is designed to improve early detection rates for colorectal cancer and other GI conditions. The system features real-time image integration from multiple cameras, advanced imaging modes, and compatibility with standard reprocessing equipment. As of June 2022, their flagship product has received FDA clearance for use in the United States.

Therapeutic areas: OncologyGastroenterology
Modalities: DeviceImaging systemEndoscope platform
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Saneso.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Saneso.

Explore the full profile